Quinazoline derivatives as medicaments
US6903096B2 · kind B2 · utility
10Cited by
18References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2001 |
| Grant date | Jun 7, 2005 |
| Priority date | — |
| Expiry date | Oct 5, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to methods to inhibit TGF-β and/or p38-α kinase using compounds of the formula or the pharmaceutically acceptable salts thereof
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.